IL234646A0 - Peptides and their use - Google Patents

Peptides and their use

Info

Publication number
IL234646A0
IL234646A0 IL234646A IL23464614A IL234646A0 IL 234646 A0 IL234646 A0 IL 234646A0 IL 234646 A IL234646 A IL 234646A IL 23464614 A IL23464614 A IL 23464614A IL 234646 A0 IL234646 A0 IL 234646A0
Authority
IL
Israel
Prior art keywords
polypeptides
Prior art date
Application number
IL234646A
Other languages
English (en)
Hebrew (he)
Inventor
O'neil Deborah
Mercer Derry
Stewart Colin
Original Assignee
Novabiotics Ltd
Deborah Oneil
Mercer Derry
Stewart Colin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novabiotics Ltd, Deborah Oneil, Mercer Derry, Stewart Colin filed Critical Novabiotics Ltd
Publication of IL234646A0 publication Critical patent/IL234646A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Polyamides (AREA)
IL234646A 2012-03-14 2014-09-14 Peptides and their use IL234646A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1204457.4A GB201204457D0 (en) 2012-03-14 2012-03-14 Polypeptides and their use
US201261620833P 2012-04-05 2012-04-05
PCT/GB2013/000112 WO2013136040A1 (en) 2012-03-14 2013-03-14 Polypeptides and their use

Publications (1)

Publication Number Publication Date
IL234646A0 true IL234646A0 (en) 2014-11-30

Family

ID=46026493

Family Applications (1)

Application Number Title Priority Date Filing Date
IL234646A IL234646A0 (en) 2012-03-14 2014-09-14 Peptides and their use

Country Status (17)

Country Link
US (1) US20140155321A1 (enExample)
EP (1) EP2825261A1 (enExample)
JP (1) JP2015516943A (enExample)
KR (1) KR20140138940A (enExample)
CN (1) CN104428036A (enExample)
AU (1) AU2013234122A1 (enExample)
CA (1) CA2866837A1 (enExample)
CL (1) CL2014002397A1 (enExample)
GB (1) GB201204457D0 (enExample)
HK (1) HK1201050A1 (enExample)
IL (1) IL234646A0 (enExample)
MX (1) MX2014010996A (enExample)
NZ (1) NZ700467A (enExample)
RU (1) RU2014139857A (enExample)
SG (1) SG11201405539QA (enExample)
WO (1) WO2013136040A1 (enExample)
ZA (1) ZA201407276B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2981037C (en) * 2015-04-03 2019-04-30 Elc Management Llc Hair treatment compositions comprising hydrolyzed wheat protein and polyquaternium-6
JP6553961B2 (ja) * 2015-06-25 2019-07-31 花王株式会社 美白剤
WO2017047299A1 (ja) * 2015-09-15 2017-03-23 富士フイルム株式会社 注射用液剤組成物
CN109700834A (zh) * 2019-01-18 2019-05-03 上海市农业科学院 一种蛹虫草固体发酵物及其抗菌用途
AR122485A1 (es) 2020-06-04 2022-09-14 Syngenta Crop Protection Ag Composiciones fungicidas
CN115381928B (zh) * 2022-10-27 2022-12-27 山东中医药大学附属医院 一种真菌提取物在制备溃疡性结肠炎治疗药物中的应用
JP2024082709A (ja) * 2022-12-09 2024-06-20 日本メナード化粧品株式会社 抗菌剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1927597T3 (en) * 2004-08-18 2017-02-13 Novabiotics Ltd ANTIBACTERIAL PEPTIDES
GB0611115D0 (en) * 2006-06-06 2006-07-19 Novabiotics Ltd Compounds and their use
GB0702020D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
GB0702022D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
EP2224901A1 (en) * 2007-12-21 2010-09-08 Basf Se Anti-dandruff compositions containing peptides

Also Published As

Publication number Publication date
RU2014139857A (ru) 2016-05-10
CA2866837A1 (en) 2013-09-19
HK1201050A1 (en) 2015-08-21
EP2825261A1 (en) 2015-01-21
CL2014002397A1 (es) 2015-02-27
US20140155321A1 (en) 2014-06-05
WO2013136040A1 (en) 2013-09-19
CN104428036A (zh) 2015-03-18
KR20140138940A (ko) 2014-12-04
AU2013234122A1 (en) 2014-10-16
SG11201405539QA (en) 2014-10-30
GB201204457D0 (en) 2012-04-25
JP2015516943A (ja) 2015-06-18
NZ700467A (en) 2016-08-26
ZA201407276B (en) 2015-06-24
MX2014010996A (es) 2014-10-13

Similar Documents

Publication Publication Date Title
IL291571A (en) cx3cr1 binding polypeptides
IL235826A0 (en) Diazaspirocycloalkane and azaspirocycloalkane
ZA201500097B (en) Modified factor x polypeptides and uses thereof
GB201201100D0 (en) Polypeptides and methods
IL236616B (en) 5-aminotetrahydroquinoline-2-carboxylic acids and their use
EP2828258A4 (en) NOVEL PYRIDOPYRIMIDINE DERIVATIVES AND THEIR USE
IL237926A0 (en) Combinations and their uses
SG11201500111VA (en) Peptides and uses thereof
GB201220474D0 (en) Polypeptides
SG11201501646PA (en) Peptides and their uses
SG11201402139UA (en) High mast2-affinity polypeptides and uses thereof
ZA201405392B (en) Substituted phenylimidazopyrazoles and use thereof
PT2855506T (pt) Péptido e utilização do mesmo
ZA201407276B (en) Polypeptides and their use
EP2825548A4 (en) MODIFIED KISSPEPTIN PEPTIDES AND USES THEREOF
SG11201504482VA (en) Beta-hexosyl-transferases and uses thereof
EP2820034A4 (en) MODIFIED ADIPONECTINPOLYPEPTIDES AND ITS USES
ZA201504462B (en) TGFß-DERIVED POLYPEPTIDES AND USES THEREOF
SMT201700322T1 (it) Composizione dermoprotettiva e dermoequilibrante
GB201210303D0 (en) Polypeptides and methods
GB201214769D0 (en) Methodsa and peptides
GB201222541D0 (en) Kiddibidet and pottibidet
IL218974A0 (en) Conaction bitwen coutch and playels
GB201202021D0 (en) Co-sleeper and breastfeeder
GB201215414D0 (en) Composition and use